{
    "nctId": "NCT05508984",
    "briefTitle": "Clinical Outcomes and Patient Satisfaction With Use of the Amma System",
    "officialTitle": "Observational Study of Clinical Outcomes and Patient Satisfaction With Use of the Amma System",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 15,
    "primaryOutcomeMeasure": "AMMA Feasibility Within PH&S System",
    "eligibilityCriteria": "Inclusion Criteria:\n\n- Women with stage I-III breast cancer are eligible to participate if:\n\n* They consent to conduct baseline (week 0) and follow-up (week 4 post-chemo) surveys/interviews\n* They consent to be photographed at baseline (week 0) and follow-up (week 4 post-chemo), to document hair retention outcomes\n* Curative-intent chemotherapy is planned with a taxane-based, anthracycline-sparing chemotherapy regimen (which includes but may not be limited to: TC x 4, T x 12, TCHP x6)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}